Preimplantation Genetic Testing (PGT) is a method which allows eliminating the risk of passing on genetic disorders to a child before the woman gets pregnant.
By examining the embryo cells, physicians are able to determine whether it has any DNA defects. For some patients, it is the only possibility of having healthy offspring.
PGD NGS method (preimplantation diagnosis based on next-generation sequencing platform) uses the most up-to-date techniques of human genome sequencing (reading of genetic information) for testing embryos and opens new diagnostic possibilities.
Thanks to preimplantation genetic testing it is possible to diagnose: Turner syndrome, Down, Edwards, Patau, Klinefelter, hemophilia, tuberous sclerosis, Huntington’s disease, cystic fibrosis, spinal muscular atrophy (SMA), Duchenne and Becker muscular dystrophy and other.
Early detection of defects and the transfer of healthy embryos reduces the risk of reproduction and birth failure of a child with a genetic defect.
Indications for testing
- Genetic problems in the family
- Carrying genetic diseases by at least one of the partners
- Female age > 37 years
- 1 or more pregnancies resulting in a miscarriage
- Failed in IVF